91 studies found for:    Open Studies | "Hypercholesterolemia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypercholesterolemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
Conditions: Hypercholesterolemia;   Heterozygous Familial Hypercholesterolemia
Interventions: Drug: EZ 10 mg/Atorva 20 mg FDC;   Drug: EZ 10 mg/Atorva 10 mg FDC
2 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
Intervention:
3 Recruiting Study of Awareness and Detection of Familial Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
4 Recruiting French Observatory of Familial Hypercholesterolemia in Cardiology
Condition: Familial Hypercholesterolemia
Intervention:
5 Recruiting Russian Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention:
6 Unknown  Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe;   Drug: Simvastatin + Ezetimibe
7 Recruiting Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: vitamin D3 tablets;   Drug: placebo tablets
8 Unknown  Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
9 Unknown  Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
10 Recruiting A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia
Condition: Moderate Hypercholesterolemia
Intervention: Dietary Supplement: Probiotics bacterial strains
11 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
12 Unknown  Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Condition: Heterozigous Familial Hypercholesterolemia
Intervention: Drug: Statins and Ezetimibe
13 Recruiting Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Conditions: Hypercholesterolemia;   Hypertension
Interventions: Drug: ETC-1002;   Drug: Placebo
14 Recruiting A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Crestor®
15 Recruiting A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Evacetrapib;   Drug: Ezetimibe;   Drug: Atorvastatin;   Drug: Placebo
16 Recruiting Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Condition: Hypercholesterolemia
Interventions: Drug: alirocumab SAR236553/REGN727;   Drug: placebo
17 Recruiting Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies
Condition: Hypercholesterolemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo (for injection training only)
18 Recruiting Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: HGP0816 5mg;   Drug: HGP0816 10mg;   Drug: HGP0816 20mg;   Drug: HCP1306 5/10mg;   Drug: HCP1306 10/10mg;   Drug: HCP1306 20/10mg
19 Not yet recruiting Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Interventions: Other: Pre-lipid apheresis;   Other: Post-lipid apheresis
20 Unknown  Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Other: Gene analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years